Connection
Voytek Slowik to Non-alcoholic Fatty Liver Disease
This is a "connection" page, showing publications Voytek Slowik has written about Non-alcoholic Fatty Liver Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.454 |
|
|
|
-
Paine-Cabrera D, Harvey LK, Robarts DR, Pritchard MT, Thyfault J, Weinman SA, Apte U, Slowik V. Leukocyte cell-derived chemotaxin 2 correlates with pediatric non-alcoholic fatty liver disease. Clin Transl Sci. 2023 12; 16(12):2719-2728.
Score: 0.899
-
Ryan JL, Sherman AK, Heble DE, Friesen CA, Daniel JF, Fischer RT, Slowik V. The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease. Clin Transl Sci. 2022 09; 15(9):2241-2250.
Score: 0.821
-
Slowik V, Wasserkrug H, Fischer RT, Connelly M, Deacy AD, Hampl S, Daniel JF. Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease. Clin Transl Sci. 2021 03; 14(2):582-588.
Score: 0.734